JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258897

Human HENMT1 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HENMT1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 3.

View Alternative Names

C1orf59, HEN1 methyltransferase homolog 1, HEN1 methyltransferase homolog 1 (Arabidopsis), HENMT_HUMAN, RP11-256E16.2, Small RNA 2' O methyltransferase, Small RNA 2''-O-methyltransferase

1 Images
Sanger Sequencing - Human HENMT1 knockout HeLa cell lysate (AB258897)
  • Sanger seq

Unknown

Sanger Sequencing - Human HENMT1 knockout HeLa cell lysate (AB258897)

Homozygous : Insertion of the selection cassette in exon 3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258897-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human HENMT1 knockout HeLa cell lysate", "number":"AB258897-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258897-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
HENMT1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HENMT1 also known as HEN1 methyltransferase homolog 1 is an enzyme with a molecular mass of approximately 55 kDa. It is expressed in the germ cells of both mammals and plants. This enzyme belongs to the small RNA methylation family and it plays an important role in the modification of small RNAs specifically piwi-interacting RNAs (piRNAs). HENMT1's primary function is transferring a methyl group to the 3' end of piRNAs protecting them against uridylation and exonucleolytic degradation keeping their integrity and stability necessary for their function.
Biological function summary

The enzyme HENMT1 participates in piRNA biogenesis. These piRNAs are part of a larger ribonucleoprotein complex that includes Piwi proteins which are essential for transposon silencing in the germline. This complex ensures the epigenetic and post-transcriptional silencing of transposable elements consequently protecting genomic integrity. HENMT1's activity is fundamental for safeguarding the genome from potential aberrations caused by active transposons.

Pathways

HENMT1 plays a significant part in the piRNA pathway which is important for gene silencing in the germline. Through this pathway it contributes to the protection of the genome against transposable elements by working alongside proteins like Piwi. The RNA interference (RNAi) pathway also involves HENMT1 although indirectly as RNAi and piRNA pathways share some mechanistic similarities in their mode of silencing unwanted genetic elements.

HENMT1 is connected to male infertility and certain cancers. Defects or malfunctions in HENMT1 can disrupt piRNA production leading to genomic instability and contributing to infertility in males. Additionally irregularities in its function might link it to cancer development possibly through faulty regulation of transposons. Other proteins like Piwi are relevant to understanding HENMT1's involvement in these conditions due to their collaborative function in the piRNA complex.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com